News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,851 Results
Type
Article (65968)
Company Profile (406)
Press Release (653477)
Section
Business (206086)
Career Advice (2424)
Deals (34731)
Drug Delivery (99)
Drug Development (83468)
Employer Resources (152)
FDA (16362)
Job Trends (15059)
News (347699)
Policy (31562)
Tag
Academia (2873)
Alliances (52831)
Alzheimer's disease (1341)
Approvals (16306)
Artificial intelligence (164)
Bankruptcy (299)
Best Places to Work (11654)
Biotechnology (276)
Breast cancer (193)
Cancer (1422)
Cardiovascular disease (119)
Career advice (2032)
CAR-T (103)
Cell therapy (312)
Clinical research (66018)
Collaboration (516)
Compensation (243)
COVID-19 (2749)
C-suite (119)
Data (1414)
Diabetes (172)
Diagnostics (6356)
Earnings (80626)
Employer resources (136)
Events (113380)
Executive appointments (412)
FDA (17047)
Funding (443)
Gene therapy (205)
GLP-1 (660)
Government (4167)
Healthcare (18925)
Infectious disease (2848)
Inflammatory bowel disease (123)
Interviews (432)
IPO (16363)
Job creations (3859)
Job search strategy (1742)
Layoffs (451)
Legal (7169)
Lung cancer (203)
Manufacturing (225)
Medical device (13597)
Medtech (13601)
Mergers & acquisitions (18574)
Metabolic disorders (482)
Neuroscience (1687)
NextGen Class of 2024 (6547)
Non-profit (4656)
Northern California (1705)
Obesity (268)
Opinion (227)
Patents (121)
People (58669)
Phase I (20582)
Phase II (28973)
Phase III (21640)
Pipeline (528)
Postmarket research (2880)
Preclinical (9297)
Radiopharmaceuticals (257)
Rare diseases (271)
Real estate (6226)
Regulatory (21709)
Research institute (2616)
Resumes & cover letters (366)
Southern California (1479)
Startups (3813)
United States (15496)
Vaccines (658)
Weight loss (208)
Date
Today (4)
Last 7 days (604)
Last 30 days (2429)
Last 365 days (36462)
2024 (36280)
2023 (41379)
2022 (52662)
2021 (57168)
2020 (55296)
2019 (47558)
2018 (36131)
2017 (34330)
2016 (34279)
2015 (40482)
2014 (33709)
2013 (29653)
2012 (30553)
2011 (30709)
2010 (29025)
Location
Africa (954)
Arizona (169)
Asia (43297)
Australia (7574)
California (3872)
Canada (1440)
China (317)
Colorado (174)
Connecticut (188)
Europe (98931)
Florida (535)
Georgia (139)
Illinois (393)
Indiana (230)
Maryland (640)
Massachusetts (3066)
Michigan (184)
Minnesota (300)
New Jersey (1122)
New York (1087)
North Carolina (827)
Northern California (1705)
Ohio (153)
Pennsylvania (905)
South America (1259)
Southern California (1479)
Texas (558)
Utah (113)
Washington State (416)
719,851 Results for "rinat pfizer global research and development".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pfizer Announces New Chief Scientific Officer and President, Research & Development
November 20, 2024
·
8 min read
Vaccines
UK Patent Win Over GSK Boosts Pfizer in Global RSV Vaccine Fight
A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, positioning both companies to compete for that market and laying down a marker for ongoing legal clashes in other parts of the world.
November 20, 2024
·
4 min read
·
Nick Paul Taylor
Sickle cell disease
Pfizer Takes Sickle Cell Drug Oxbryta Off Global Market, Cites Risk of Death
Based on new safety signals, Pfizer on Wednesday announced that Oxbryta’s overall benefit “no longer outweighs the risk” in patients with sickle cell disease. Guggenheim Securities analysts said the setback increases investor frustrations with the company’s business development track record.
September 26, 2024
·
2 min read
·
Tristan Manalac
Drug development
5 Sickle Cell Therapies to Watch Following Pfizer’s Oxbryta Exit
In the wake of Pfizer’s voluntary market withdrawal of the popular sickle cell disease therapy,
BioSpace
looks at five investigational drugs currently making their way through the pipeline.
October 21, 2024
·
4 min read
·
Kate Goodwin
Executive Appointments
Pfizer Shakes Up C-Suite, Elevating Cancer Chief Boshoff to CSO
Chris Boshoff will take over as Pfizer’s next chief scientific officer as of January 1, replacing Mikael Dolsten who led the pharma through the COVID-19 pandemic. The move comes weeks after Pfizer faced pressure from activist investor Starboard Value.
November 20, 2024
·
2 min read
·
Annalee Armstrong
Phase III
Pfizer’s Ibrance Improves Survival in New Breast Cancer Indication
Pfizer, facing increasing pressure from Novartis, is touting a Phase III win for Ibrance as the first clinical evidence supporting the CDK4/6 inhibitor class’ use in patients with a specific type of breast cancer.
December 12, 2024
·
1 min read
·
Annalee Armstrong
Drug Development
BridgeBio Wins FDA Approval for ATTR-CM Drug, Launching Competition With Pfizer
BridgeBio secured approval for Attruby Friday, along with the all-important mortality benefit that could give the drug a significant boost in the market against Pfizer’s tafamidis and potentially Alnylam’s Amvuttra.
November 23, 2024
·
8 min read
·
Heather McKenzie
Podcast
BMS’ Schizophrenia Approval, Pfizer’s Sudden Sickle Cell Withdrawal and Roche’s Pharma Day
Bristol Myers Squibb wins approval for the first novel schizophrenia drug in decades; Pfizer pulls Oxbryta from the market; new IVF and abortion laws could derail women’s health research; Roche touts CDK inhibitor deal and obesity pipeline and
BioSpace
heads to Meeting on the Mesa.
October 2, 2024
·
1 min read
·
Heather McKenzie
Government
Lilly, Pfizer Execs Sing Optimistic Tune on Incoming Admin After Trump Dinner
A week after dining with Trump and his team at Mar-a-Lago, leaders at Pfizer and Eli Lilly have publicly stated that they intend to collaborate with the incoming administration on key issues affecting the pharma industry.
December 12, 2024
·
2 min read
·
Tristan Manalac
Business
Department of Health - Abu Dhabi Partners with Pfizer to Advance Research in Sickle Cell Disease and Beyond
The Department of Health – Abu Dhabi, the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding with Pfizer Gulf FZ LLC, a global pharmaceutical company during BIO 2024 International Convention.
June 3, 2024
·
4 min read
1 of 71,986
Next
